Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

MYH6 Gene Atrial Septal Defect Type 3 Genetic Test

Executive Summary & Core Metrics

  • 99.9% Diagnostic Sensitivity – ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited NGS with Sanger confirmation for every pathogenic variant.
  • VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – DHA-licensed phlebotomists collect blood or DNA at your doorstep, 8 AM–11 PM, 7 days a week.
  • Telephonic Post-Test Clinical Guidance – Discuss your results with our clinical team to contextualise genetic findings.
  • Direct Billing Verification – WhatsApp your insurance card to +971 54 548 8731 for instant eligibility check.

Test Overview & Methodology

The MYH6 gene encodes cardiac alpha-myosin heavy chain; pathogenic variants cause autosomal dominant atrial septal defect type 3 (ASD3). This comprehensive NGS test sequences all coding exons and flanking intronic regions to identify disease-causing mutations, guiding personalised cardiac surveillance and family risk assessment.

Feature Our Test — NGS + Sanger Closest Alternative — Targeted Sanger Only
Methodology NGS (30× mean coverage) with variant confirmation by Sanger sequencing Sanger sequencing of limited hotspots
Analytical Sensitivity >99.9% for SNVs, indels, and copy number variants (CNVs) ~95% for common variants; may miss deep-intronic/CNV changes
Turnaround Time 3–4 weeks 6–8 weeks
Price 2800 AED Variable, often >3500 AED

Physician Insight & Safety Protocols

"A positive MYH6 variant can explain a lifelong atrial septal defect, yet penetrance varies; a negative result does not exclude other genetic or environmental causes. Always integrate this result with echocardiography and cardiology follow-up. I encourage patients to use this information proactively, not fearfully."

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Safety Exclusion Criteria & Emergency Red Flags

  • Minors without parental consent: UAE Child Protection Law requires documented parental/guardian consent for genetic testing in individuals under 18.
  • No genetic counselling: All patients must undergo a pre-test genetic counselling session to document family pedigree and understand implications.
  • Acute cardiac emergency: This is an elective genetic test. If you experience sudden chest pain, palpitations, syncope, or severe shortness of breath, call 998 or go to the nearest emergency department immediately.
⚠️

Medication Warning: Do not discontinue or adjust any prescribed cardiac, anticoagulant, or other medication without consulting your treating physician. Genetic results do not replace ongoing clinical management.

Patient FAQ & Clinical Guidance

1. What is the MYH6 gene and how does it relate to atrial septal defect type 3?

The MYH6 gene codes for cardiac alpha-myosin heavy chain, and inherited mutations disrupt heart septation leading to ASD3.

2. Who should consider this genetic test?

Individuals with a personal or family history of atrial septal defect, especially when diagnosed before age 40, should consider testing.

3. How is the test performed and what does the process involve?

A certified phlebotomist collects 3-5 mL of blood at your home via VIP Mobile Phlebotomy, then NGS and Sanger confirmation deliver results in 3-4 weeks.

UAE Regulatory & Data Privacy Adherence

This service strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is handled under DHA-approved protocols.

Clinical & Logistical Metadata

Test Name MYH6 Gene Atrial Septal Defect Type 3 Genetic Test
Price (AED) 2800 AED
Turnaround Time 3–4 weeks
Sample Type / Matrix Peripheral Whole Blood (3-5 mL) or Buccal Swab (in pediatric cases)
Methodology Used Next-Generation Sequencing (NGS) with Sanger confirmation
ICD-10-CM Code Q21.1
LOINC Code 81319-3
DHA Facility License & Laboratory Address DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab Branding: DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians